Literature DB >> 22441225

Functional status, respiratory muscle strength, and quality of life in patients with cirrhosis.

Lucas H Galant1, Luiz A Forgiarini Junior, Alexandre S Dias, Cláudio A Marroni.   

Abstract

BACKGROUND: Liver diseases are responsible for metabolic disorders and loss of muscle mass and function that affect functional status and quality of life (QoL).
OBJECTIVE: To compare exercise capacity, respiratory muscle strength, and QoL in liver transplant candidates with cirrhosis of the following etiologies: hepatitis C virus (HCV), hepatitis B virus (HBV), and alcoholic cirrhosis (AC).
METHODS: Cross-sectional study comprising 86 patients divided into three groups: HCV (40 patients), HBV (14 patients), and AC (32 patients). Patients were evaluated using the Six-Minute Walk Test (6MWT), manometry, and the QoL questionnaire SF-36.
RESULTS: The AC group showed the lowest performance in the 6MWT (meters) compared to the HBV and HCV groups (373.50 ± 50.48, 464.16 ± 32, and 475.94 ± 27.84, respectively, p=0.001). In the domains of the SF-36, the AC group had lower scores for functional capacity and physical limitations when compared to the HBV and HCV groups (p=0.001). In the comparison of respiratory muscle strength, the AC group had lower MIP (cmH2O) compared to the HBV and HCV groups (-65.54 ± 11.28, -71.61 ± 6.96, -82.44 ± 13.71, respectively, p=0.001). The MEP (cmH2O) in the AC group was also lower than in the HBV and HCV groups (65.13 ± 10.74, 82.44 ± 13.87, 83.44 ± 12.20, respectively, p=0.001).
CONCLUSION: The AC group showed worse exercise capacity, respiratory muscle strength, and QoL compared to patients with HCV and HBV.

Entities:  

Mesh:

Year:  2012        PMID: 22441225

Source DB:  PubMed          Journal:  Rev Bras Fisioter


  12 in total

1.  Exercise manual for liver disease patients.

Authors:  Vivian Limongi; Daniele Costa Dos Santos; Aurea Maria de Oliveira da Silva; Ilka de Fátima Santana Ferreira Boin; Raquel Silveira Bello Stucchi
Journal:  World J Transplant       Date:  2016-06-24

2.  Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.

Authors:  Patrick McCabe; Artin Galoosian; Robert J Wong
Journal:  Dig Dis Sci       Date:  2019-10-22       Impact factor: 3.199

3.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

4.  Treatment to improve nutrition and functional capacity evaluation in liver transplant candidates.

Authors:  Srinivasan Dasarathy
Journal:  Curr Treat Options Gastroenterol       Date:  2014-06

5.  The Perme scale score as a predictor of functional status and complications after discharge from the intensive care unit in patients undergoing liver transplantation.

Authors:  Camila Santos Pereira; Alexandra Torres de Carvalho; Adriane Dal Bosco; Luiz Alberto Forgiarini Júnior
Journal:  Rev Bras Ter Intensiva       Date:  2019 Jan-Mar

6.  Physical exercise for people with cirrhosis.

Authors:  Luise Aamann; Gitte Dam; Anders R Rinnov; Hendrik Vilstrup; Lise Lotte Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-12-21

7.  The Benefits of Neuromuscular Electrical Stimulation in the Muscular and Functional Capacity of Patients With Liver Cirrhosis: Protocol for a Randomized Clinical Trial.

Authors:  Carolina Luana de Mello; Thaís Martins Albanaz da Conceição; Tarcila Dal Pont; Catherine Corrêa Peruzzolo; Mariana Nunes Lúcio; Elaine Paulin
Journal:  Clin Med Insights Gastroenterol       Date:  2018-11-26

Review 8.  Liver transplantation and alcoholic liver disease: History, controversies, and considerations.

Authors:  Claudio Augusto Marroni; Alfeu Medeiros Fleck; Sabrina Alves Fernandes; Lucas Homercher Galant; Marcos Mucenic; Mario Henrique de Mattos Meine; Guilherme Mariante-Neto; Ajacio Bandeira de Mello Brandão
Journal:  World J Gastroenterol       Date:  2018-07-14       Impact factor: 5.742

9.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

Review 10.  Exercise as an intervention for patients with end-stage liver disease: Systematic review.

Authors:  Cameron T Locklear; Pegah Golabi; Lynn Gerber; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.